Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
Clinical trial NCT00195104 · COMPLETED
Trial details
- NCT number
- NCT00195104
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-17
- Primary completion
- 2006-03-17
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.